Genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer
- Citation:
- JAMA vol 305 (18) 1873-1881
- Year:
- 2011
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Received
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Grants:
- CA33601, CA77597, P30 CA016672, CA41287, U10 CA031946, CA77651, U10 CA033601, CA60138, U10 CA077597, CA37347, CA16450, U10 CA041287, R43 CA130188, U10 CA047559, U10 CA077651, 1 R01 CA106290, CA47559, R01 CA106290, CA31946
- Corr. Author:
- Authors:
- Christos Hatzis Lajos Pusztai Vicente Valero Daniel J. Booser Laura Esserman Ana Lluch Tatiana Vidaurre Frankie Holmes Eduardo Souchon Miguel Martin José Cotrina Henry Gomez Rebekah Hubbard J. Ignacio Chacón Jaime Ferrer-Lozano Richard Dyer Meredith Buxton Yun Gong Yun Wu Nuhad Ibrahim Eleni Andreopoulou Naoto T. Ueno Kelly Hunt Wei Yang Arlene Nazario Angela DeMichele Joyce O'Shaughnessy Gabriel N. Hortobagyi W. Fraser Symmans
- Networks:
- Study
- CALGB-150007
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- N/A
- Keywords:
- Article